Valuation Ipsen

Stocks

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-06-11 EDT			5-day change	1st Jan Change
157.10 ^EUR	+1.29%		+3.83%	+32.02%

06-05	HC Wainwright Starts Ipsen Coverage with Buy Rating	MT
06-02	Fulcrum plummets over 50% after scrapping lead sickle-cell drug on FDA concerns	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,621	8,279	8,912	9,155	9,770	12,898	-	-
Change	-	25.05%	7.65%	2.72%	6.72%	32.02%	-	-
Enterprise Value (EV) ¹	6,758	7,894	8,860	9,020	9,225	11,536	10,526	9,745
Change	-	16.81%	12.22%	1.81%	2.28%	25.05%	-8.75%	-7.42%
P/E Ratio	10.4x	12.9x	14x	26.7x	22.4x	14.5x	14.2x	14.1x
PBR	2.42x	-	2.36x	2.22x	2.3x	2.58x	2.13x	1.84x
PEG	-	20.02x	-13.67x	-0.6x	0.8x	0x	5.77x	22.23x
Capitalization / Revenue	2.31x	2.74x	2.85x	2.69x	2.49x	3.03x	2.92x	2.81x
EV / Revenue	2.36x	2.61x	2.83x	2.65x	2.35x	2.71x	2.39x	2.13x
EV / EBITDA	5.8x	5.86x	10.1x	7.52x	6.67x	6.96x	6.25x	5.86x
EV / EBIT	6.68x	7.08x	8.85x	8.13x	7.13x	8.14x	7.33x	6.75x
EV / FCF	8.31x	9.02x	12.5x	11.6x	8.93x	10.7x	9.2x	8.35x
FCF Yield	12%	11.1%	8.02%	8.59%	11.2%	9.38%	10.9%	12%
Dividend per Share ²	1.2	1.2	1.2	1.4	1.4	1.431	1.496	1.599
Rate of return	1.49%	1.19%	1.11%	1.26%	1.18%	0.91%	0.95%	1.02%
EPS ²	7.76	7.81	7.73	4.15	5.32	10.81	11.07	11.15
Distribution rate	15.5%	15.4%	15.5%	33.7%	26.3%	13.2%	13.5%	14.3%
Net sales ¹	2,869	3,025	3,128	3,401	3,929	4,254	4,412	4,583
EBITDA ¹	1,166	1,348	881.4	1,200	1,383	1,656	1,685	1,664
EBIT ¹	1,011	1,115	1,001	1,109	1,294	1,417	1,437	1,443
Net income ¹	646.6	647.5	647.2	347.3	444.5	923.1	915.6	919.1
Net Debt ¹	137.8	-384.7	-52.9	-134.9	-544.5	-1,362	-2,372	-3,152
Reference price ²	80.50	100.50	107.90	110.70	119.00	157.10	157.10	157.10
Nbr of stocks (in thousands)	82,243	82,380	82,599	82,700	82,100	82,100	-	-
Announcement Date	2/11/22	2/9/23	2/8/24	2/13/25	2/12/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IPSEN	14.35x	2.67x	6.87x	0.92%	14.71B
ELI LILLY AND COMPANY	33.25x	12.09x	24.89x	0.6%	1,013B
JOHNSON & JOHNSON	25.49x	5.87x	15.97x	2.24%	574B
ABBVIE INC.	27.54x	6.71x	13.71x	3.05%	397B
ROCHE HOLDING AG	17.38x	4.29x	10.55x	3.1%	324B
ASTRAZENECA PLC	22.74x	4.73x	13.45x	1.85%	280B
NOVARTIS AG	20.72x	5.35x	13x	3.04%	273B
AMGEN INC.	21.96x	5.91x	10.33x	2.99%	182B
NOVO NORDISK A/S	12.52x	4.69x	9.6x	4.01%	194B
GILEAD SCIENCES, INC.	-43.47x	5.27x	29.72x	2.67%	151B
Average	15.25x	5.76x	14.81x	2.45%	340.34B
Weighted average by Cap.	22.63x	7.43x	17.31x	2.11%